David Jin - 19 Dec 2024 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Reporting relationship: Chief Financial Officer
Issuer ticker: FBIO
Reported as of: 19 Dec 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Dec 2024, 16:30:05 UTC
Prior SEC filing: 29 Oct 2024
Next SEC filing: 01 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ David Jin

Key filing fact

David Jin filed Form 4 for Fortress Biotech, Inc. (FBIO) on 23 Dec 2024.

Key facts

This page summarizes David Jin's Form 4 filing for Fortress Biotech, Inc. (FBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Dec 2024, 16:30.

Change

Previous filing in this sequence was filed on 29 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBIO transaction

Common Stock, par value $0.001

Award

Transaction value: $0
Shares: +1,000,000
Change %: +415%
Price: $0.000000
Shares after: 1,240,893
Date: 19 Dec 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of 1,000,000 restricted stock units which will vest in 16 equal quarterly installments beginning after December 20, 2024. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.

Footnote F2

Total holdings include 1,230,000 shares underlying deferred restricted stock units.